Australia’s world-leading healthcare system is driven by a highly developed sector comprising of providers, specialists, and technological and physical infrastructure.
The challenges the industry faced throughout the pandemic including affordability and access, variability of patient outcomes, technological integration, and increased demand for innovative medicines and diagnostic tools, has driven recent M&A and capital market activity within the Australian healthcare sector.
The sector’s stability and long-term growth prospects, particularly in pharmaceuticals and biotechnology, is attractive characteristic for institutional and retail investors, resulting in the ASX healthcare index outperforming the resources, technology, industrial and financial sectors over the last five years.
In this edition of BDO’s Healthcare Highlights, our leading corporate finance experts analyse the Australian healthcare industry - detailing trading and performance insights, recent M&A activity, the top deals of FY22 and an overview of capital raises in the industry. This edition also features a spotlight on the key trends defining the sector.
What’s covered in this edition of BDO’s healthcare update?
- Industry composition
- Trading performance
- M&A transactions
- Capital raises
- Key trends defining the sector
Healthcare on the ASX
Source: S&P Capital IQ, BDO analysis - Click to expand in new window
ASX Healthcare market capitalisation by sub-sector
Source: S&P Capital IQ, BDO analysis - Click to expand in new window
To stay up-to-date with the latest trends and news in the healthcare sector, see our healthcare insights.
For more information, contact your local adviser.